0.3751
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$0.3695
Aprire:
$0.3691
Volume 24 ore:
378.76K
Relative Volume:
0.19
Capitalizzazione di mercato:
$15.37M
Reddito:
$62.71M
Utile/perdita netta:
$-10.48M
Rapporto P/E:
-0.5954
EPS:
-0.63
Flusso di cassa netto:
$-13.77M
1 W Prestazione:
+16.26%
1M Prestazione:
+12.64%
6M Prestazione:
-52.59%
1 anno Prestazione:
-92.77%
Prophase Labs Inc Stock (PRPH) Company Profile
Nome
Prophase Labs Inc
Settore
Industria
Telefono
(215) 345-0919
Indirizzo
711 STEWART AVE, SUITE 200, NEW YORK, PA
Confronta PRPH con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
PRPH
Prophase Labs Inc
|
0.3701 | 14.95M | 62.71M | -10.48M | -13.77M | -0.63 |
![]()
TMO
Thermo Fisher Scientific Inc
|
396.38 | 152.34B | 42.90B | 6.52B | 6.72B | 17.05 |
![]()
DHR
Danaher Corp
|
188.98 | 135.39B | 23.82B | 3.77B | 4.90B | 5.15 |
![]()
IDXX
Idexx Laboratories Inc
|
514.45 | 41.54B | 3.93B | 894.97M | 837.70M | 10.82 |
![]()
A
Agilent Technologies Inc
|
110.89 | 31.59B | 6.63B | 1.17B | 1.19B | 4.05 |
![]()
IQV
Iqvia Holdings Inc
|
138.97 | 24.31B | 15.50B | 1.33B | 2.16B | 7.34 |
Prophase Labs Inc Stock (PRPH) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2021-12-20 | Iniziato | H.C. Wainwright | Buy |
2021-10-13 | Downgrade | Dawson James | Buy → Neutral |
2021-01-20 | Iniziato | Dawson James | Buy |
Prophase Labs Inc Borsa (PRPH) Ultime notizie
ProPhase Labs, Inc. (NASDAQ:PRPH) Q1 2025 Earnings Call Transcript - MSN
ProPhase Labs’ Earnings Call: Strategic Moves Amid Challenges - TipRanks
ProPhase Labs Inc (PRPH) Q1 2025 Earnings Call Highlights: Strategic Moves and Financial Challenges - Yahoo Finance
ProPhase Labs Inc (PRPH) Q1 2025 Earnings Call Highlights: Strat - GuruFocus
ProPhase Labs Reports Q1 2025 Earnings and Strategic Developments - TipRanks
Transcript : ProPhase Labs, Inc., Q1 2025 Earnings Call, May 20, 2025 - marketscreener.com
ProPhase Labs, Inc. SEC 10-Q Report - TradingView
Earnings call transcript: ProPhase Labs beats Q1 2025 EPS forecast, stock rises - Investing.com
ProPhase Labs earnings beat by $0.05, revenue fell short of estimates - Investing.com Canada
Prophase Labs Inc reports results for the quarter ended March 31Earnings Summary - TradingView
ProPhase Labs, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com
ProPhase (PRPH) Awaits Potential $50 Million Insurance Recovery - GuruFocus
ProPhase (PRPH) Awaits Potential $50 Million Insurance Recovery | PRPH Stock News - GuruFocus
ProPhase (PRPH) Explores Strategic Sale of Nebula Genomics | PRPH Stock News - GuruFocus
ProPhase Labs (PRPH) Anticipates Extension for Nasdaq Listing | PRPH Stock News - GuruFocus
PRPH Streamlines Operations with Strategic Changes | PRPH Stock News - GuruFocus
ProPhase Labs Announces Financial Results for the Three Months E - GuruFocus
ProPhase Labs Inc Reports Q1 2025 EPS of $(0.13) and Revenue of $1.4 Million, Missing Estimates - GuruFocus
ProPhase Labs (PRPH) Focuses on Strategic Growth Amid Revenue De - GuruFocus
PROPHASE LABS Earnings Results: $PRPH Reports Quarterly Earnings - Nasdaq
ProPhase Labs Announces Financial Results for the Three Months Ended March 31, 2025 | PRPH Stock News - GuruFocus
ProPhase Labs Announces Financial Results for the Three Months Ended March 31, 2025 - GlobeNewswire
ProPhase Labs Slashes Costs by $8M, Reveals Three Major Value Drivers Including Potential $50M Collection - Stock Titan
ProPhase Labs Delays Form 10-Q Filing - TipRanks
ProPhase Labs Inc. to Present First Quarter 2025 Financial Results on May 20, 2025 - GlobeNewswire
ProPhase Labs, Inc. (NASDAQ:PRPH) Shares Bought by Renaissance Technologies LLC - Defense World
ProPhase Labs, Inc. (NASDAQ:PRPH) Q4 2024 Earnings Call Transcript - MSN
Geode Capital Management LLC Boosts Stake in ProPhase Labs, Inc. (NASDAQ:PRPH) - Defense World
PRPH’s Stock Market Puzzle: Piecing Together 2023’s Performance - investchronicle.com
There is no doubt that ProPhase Labs Inc (PRPH) ticks all the boxes. - Sete News
Metric Analysis: ProPhase Labs Inc (PRPH)’s Key Ratios in the Limelight - DWinneX
What was ProPhase Labs Inc (PRPH)’s performance in the last session? - uspostnews.com
Press Release Distribution & PR Platform - ACCESS Newswire
ProPhase Labs Inc (PRPH) is a good investment, but the stock may be overvalued - uspostnews.com
Daily Market Movement: ProPhase Labs Inc (PRPH) Sees a 0.54 Increase, Closing at 0.35 - DWinneX
Monitoring ProPhase Labs Inc (PRPH) after recent insider movements - knoxdaily.com
ProPhase Labs Inc (PRPH) Stock: Navigating Market Highs and Lows in 52 Weeks - investchronicle.com
Investors Take Advantage Of 7.67% Gain In ProPhase Labs Inc (NASDAQ: PRPH) - Stocksregister
Form 424B5Prospectus [Rule 424(b)(5)] - ADVFN
ProPhase Labs, Inc. (NASDAQ:PRPH) Short Interest Up 50.0% in March - Defense World
ProPhase Labs Closes $23.6M Asset Sale to Streamline Business Strategy - citybuzz -
ProPhase Labs Inc (NASDAQ: PRPH): Forecast Weak In 2025, Up -95.29% - Stocksregister
HighTower Advisors LLC Acquires 57,736 Shares of ProPhase Labs, Inc. (NASDAQ:PRPH) - Defense World
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
ProPhase Labs Inc (PRPH) Q4 2024 Earnings Call Highlights: Strategic Moves and Financial Challenges By GuruFocus - Investing.com Canada
ProPhase Labs Inc (PRPH) Q4 2024 Earnings Call Highlights: Strategic Moves and Financial Challenges - Yahoo Finance
A Tale of Resilience: ProPhase Labs Inc Amid Stock Market Turbulence - investchronicle.com
ProPhase Labs Inc (PRPH) Q4 2024 Earnings Call Highlights: Strat - GuruFocus
ProPhase Labs Delays Yearly Report Filing - TipRanks
Prophase Labs Inc reports results for the quarter ended December 31Earnings Summary - TradingView
ProPhase Labs, Inc. SEC 10-K Report - TradingView
Prophase Labs Inc Azioni (PRPH) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):